There's A Lot To Like About Xiamen Amoytop Biotech's (SHSE:688278) Upcoming CN¥0.62 Dividend

Simply Wall StMay 5 18:51 ET

Additional Considerations Required While Assessing Xiamen Amoytop Biotech's (SHSE:688278) Strong Earnings

Simply Wall StMay 2 18:44 ET

Xiamen Amoytop Biotech's Q1 Profit Climbs 41%, Operating Income Rises 23%; Shares Drop 8%

MT NewswiresApr 23 01:12 ET

Tebao Biotech: Tebao Biotech: Report for the first quarter of 2025

SZSIApr 22 12:00 ET · Announcements

Tebao Biotech: Report for the first quarter of 2025

SZSIApr 22 12:00 ET · Announcements

Xiamen Amoytop Biotech (688278.SH): In the first quarter, the net income is 0.182 billion yuan, a year-on-year increase of 41.40%.

Gelonghui, April 22 - Xiamen Amoytop Biotech (688278.SH) announced its first quarter report for 2025, achieving revenue of 0.673 billion yuan, a year-on-year increase of 23.48%; net income attributable to shareholders of the listed company of 0.182 billion yuan, a year-on-year increase of 41.40%; basic EPS of 0.45 yuan.

Gelonghui FinanceApr 22 06:18 ET